S_lugdunensis_AMR
Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options
Staphylococcus lugdunensis is a CoNS with an unusual pathogenicity resembling that of S. aureus. Unlike other CoNS, S. lugdunensis remains susceptible to most antibiotics. The resistance to penicillin varies widely (range: 15–87% worldwide), whereas methicillin resistance is still rare. Objectives: We aimed to evaluate treatment options for infections caused by S. lugdunensis, and more specifically to investigate whether penicillin G could be a better treatment choice than oxacillin. Methods: Susceptibility testing was performed using the disc diffusion method for penicillin G, cefoxitin, trimethoprim/sulphamethoxazole, erythromycin, clindamycin, gentamicin, norfloxacin, fusidic acid, rifampicin, and fosfomycin. Isolates susceptible to penicillin G were further tested with a gradient test for penicillin G and oxacillin. Results: Of the 540 clinical isolates tested, 74.6% were susceptible to penicillin G. Among these penicillin-susceptible isolates, the MIC50 and MIC90 values for penicillin G were three-fold lower than for oxacillin. A majority of the isolates were susceptible to all other antibiotics tested. Breakpoints for fosfomycin have not yet been defined, and so no conclusions could be drawn. Two isolates were resistant to cefoxitin and carried the mecA gene; whole-genome sequencing revealed that both harboured the SCCmec element type IVa(2B). Conclusions: S. lugdunensis isolated in Sweden were susceptible to most tested antibiotics. Penicillin G may be a more optimal treatment choice than oxacillin. Although carriage of the mecA gene is rare among S. lugdunensis, it does occur.